Keywords: b-ms, medarex, up, 480m, alliance, drug, major

B-MS and Medarex in up to $480M alliance

Article | 15 November 2004

Print This

Drug major Bristol-Myers Squibb has entered into a global collaboration with fellow US firm Medarex for the development and commercialization ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in